Annick Schwebig

Annick Schwebig has served as a member of the Board of Directors since February 2017. Mrs. Schwebig was the founder and Chief Executive Officer of Actelion Pharmaceuticals France from 2000 to 2015, a laboratory specializing in the development of drugs for orphan diseases. She has held senior positions in the pharmaceutical industry as Vice-President of Medical Affairs France and Vice-President of Research and Development Europe at Bristol-Myers Squibb from 1983 to 2000.

Mrs. Schwebig has been a member of the Board of Directors of Cellectis since 2011. She is a graduate of the Faculty of Medicine of Paris.